• Corteva entered a co-exclusive supply and license deal with FMC for rimisoxafen herbicide technology in North and South America corn, soybean markets.
• FMC keeps ownership rights. Corteva will source the active ingredient from FMC.
• Both groups will develop, sell separate exclusive premix formulations. The agreement runs through the next decade.
• Corteva will make an initial prepurchase payment of USD 200 million for product supply.
• First commercial sales expected by the end of the decade, subject to regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corteva Inc. published the original content used to generate this news brief on June 16, 2026, and is solely responsible for the information contained therein.